ALC:NYSE
Alcon AG
၆၃.၀၁ US$
arrow_downward
-၀.၂၈%(-၀.၁၈) 1D
အောက် ၇, GMT-၄ ၁၅:၅၅:၄၆ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
၆၃.၃၆ US$
High
၆၃.၆၈ US$
Low
၆၂.၉၄ US$
Mkt. cap
ဋေ ၂.၆၆ ထ
Avg. vol.
၁.၆၁ သန်း
Volume
၁.၁၅ သန်း
52-wk high
၈၇.၆၄ US$
52-wk low
၆၁.၈၄ US$
Beta
၀.၈၈
Shares outstanding
၄၈.၃၄ ကုဋေ
No. of employees
၂ သောင်း
Open
၆၃.၃၆ US$
High
၆၃.၆၈ US$
Low
၆၂.၉၄ US$
Mkt. cap
ဋေ ၂.၆၆ ထ
Avg. vol.
၁.၆၁ သန်း
Volume
၁.၁၅ သန်း
52-wk high
၈၇.၆၄ US$
52-wk low
၆၁.၈၄ US$
Beta
၀.၈၈
Shares outstanding
၄၈.၃၄ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
AD HOC NEWS
·
ပြီးခဲ့သည့် ၃ နာရီ
EUR 56.57 at Lang & Schwarz: Alcon stock after-hours plus 0.86 percent versus the prior close
AD HOC NEWS
·
ပြီးခဲ့သည့် ၈ နာရီ
Alcon stock trades at CHF 52.90 before November 10 earnings
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁ ရက်
Alcon stock after-hours at EUR 56.24: minus 1.88 percent versus the Lang & Schwarz prior close
AD HOC NEWS
·
ပြီးခဲ့သည့် ၂ ရက်
Alcon stock pre-market at EUR 56.31: minus 0.46 percent
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees၂.၅ သောင်း
Founded၁၉၄၅
Headquartersဂျနီဗာမြို့, Geneva, ဆွစ်ဇာလန်
Sector-
Websitealcon.com